Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors
Abstract Background Programmed cell death 1 inhibitors have revolutionized therapy for cancer by their outstanding effectiveness.However, they may cause adverse effects, among which inflammatory myopathy is one of the most disabling.To elucidate its mechanism, we analysed muscle biopsies and compared them with other inflammatory myopathies.Methods